Sign Up:

First Name *

* Required

Last Name *

* Required

Email *

* Required

Job Title *

* Required

Company *

* Required

Zip/Postal Code *

* Required

Country *

* Required

Job Function *

* Required

Organization Type *

* Required

I would like to receive additional technical and educational content from the sponsor. *

YesNo * Required

To view GEN’s privacy statement click here.

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Next-Generation mRNA Design: Increasing mRNA potency with a New Cap Analog

Available On Demand

Already Registered? Click Here

mRNA vaccines and therapeutics are expanding rapidly, fueled in part by the extraordinary distribution and success of the COVID-19 vaccines. An essential part of the success of any mRNA therapeutic is the 5’ cap structure, which is critical to the stability and expression of an mRNA.

In this webinar, Dr. Chunping Xu, Director of Chemistry R&D for TriLink Biotechnologies, will discuss the latest progress in next-generation mRNA design. Attendees will learn about how major capping strategies differ in their manufacturing costs, time, complexity, and availability. In addition, Dr. Xu will show how TriLink is continuing to innovate in this technology as the company debuts a novel Cap1 structure.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

Presenters

Chunping Xu

Director of Chemistry R&D
TriLink BioTechnologies
View Biography